Manish A. Shah, MD, on Gastric Cancer: Results From the RAINFALL Trial

2018 Gastrointestinal Cancers Symposium
Tweet this page

Manish A. Shah, MD, of Weill Cornell Medicine, discusses phase III study findings on cisplatin plus capecitabine or fluorouracil with or without ramucirumab as first-line therapy in patients with metastatic gastric or gastroesophageal junction adenocarcinoma (Abstract 5).

Jun

Today In Oncology

FDA Grants Priority Review to Expanded Use of Gardasil 9 in Women and Men Aged 27 to 45 for the Prevention of Certain HPV-Related Cancers and Diseases

Statement From FDA Commissioner on Agency Efforts to Advance the Patient Voice in Medical Product Development and Regulatory Decision-Making

AMA Plans Advocacy Outreach to Expand Colorectal Screening

Ibrutinib in Relapsed or Refractory Follicular Lymphoma

Suboptimal Use of Initial Chemotherapy in Newly Diagnosed AML

;